Bio

Hao is active in the firm’s Fund IV investments in Warren Averett Asset Management, Fund III investments in Better Being, Denodo and Monotype Imaging. He previously was involved with the firm’s exited investment in Innovative and Dealer-FX. Prior to joining HGGC, Hao worked as an Associate at Onex Partners, where he was actively involved in evaluating potential acquisitions and conducting due diligence on new investment opportunities. Previously, he was as an Investment Banking Analyst at Goldman, Sachs & Co.